BDK advised Mylan in relation to the acquisition of Abbott’s established products business (EPD Business) in Bosnia and Herzegovina, as part of a USD 5.3 billion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business. BDK team was led by Partners Vladimir Dašić and Mirjana Mladenović on the corporate law and transactional side […]